Abstract
Antimicrobial agents, systemic and/or local, are thought by some to be effective agents for treating periodontal infections. Here the authors determine the costs and benefits of local delivery agents for treating periodontal disease. Applying this cost-benefit analysis to patient care, however, will depend upon a clinician's expertise and a patient's value system.
Publication types
-
Meta-Analysis
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Administration, Topical
-
Anti-Bacterial Agents / administration & dosage*
-
Anti-Bacterial Agents / economics
-
Anti-Infective Agents / administration & dosage
-
Anti-Infective Agents, Local / administration & dosage
-
Cellulose / administration & dosage
-
Chlorhexidine / administration & dosage
-
Chlorhexidine / analogs & derivatives*
-
Cost-Benefit Analysis
-
Doxycycline / administration & dosage
-
Doxycycline / analogs & derivatives*
-
Drug Approval
-
Drug Costs
-
Drug Delivery Systems* / economics
-
Gels / administration & dosage
-
Glycerides / administration & dosage
-
Humans
-
Metronidazole / administration & dosage
-
Metronidazole / analogs & derivatives*
-
Microspheres
-
Minocycline / administration & dosage
-
Periodontal Diseases / drug therapy*
-
Periodontal Diseases / microbiology
-
Randomized Controlled Trials as Topic
-
Research Design
-
Risk Assessment
-
Sesame Oil / administration & dosage
-
Tetracycline / administration & dosage
-
Treatment Outcome
Substances
-
Actisite
-
Anti-Bacterial Agents
-
Anti-Infective Agents
-
Anti-Infective Agents, Local
-
Elyzol Dentalgel
-
Gels
-
Glycerides
-
Metronidazole
-
Sesame Oil
-
Cellulose
-
Tetracycline
-
Minocycline
-
chlorhexidine gluconate
-
Doxycycline
-
Chlorhexidine